A Pilot Study of Ipilumimab and Radiation in Poor Prognosis Melanoma
Status:
Completed
Trial end date:
2018-09-01
Target enrollment:
Participant gender:
Summary
This is a pilot study assessing the safety of the combination of ipilimumab administered
concurrently with radiotherapy for patients with locally advanced or unresectable melanoma
and patients at high risk for recurrence after resection.